{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:16:29Z","timestamp":1791850589121,"version":"4.3.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,10,30]],"date-time":"2006-10-30T00:00:00Z","timestamp":1162166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1007\/s11102-006-0409-4","type":"journal-article","created":{"date-parts":[[2006,10,31]],"date-time":"2006-10-31T14:44:02Z","timestamp":1162305842000},"page":"297-303","source":"Crossref","is-referenced-by-count":78,"title":["Acromegaly"],"prefix":"10.1007","volume":"9","author":[{"given":"Massimo","family":"Scacchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cavagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,30]]},"reference":[{"key":"409_CR1","first-page":"526","volume":"85","author":"A Giustina","year":"2000","unstructured":"Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, Veldhuis J, Wass J, Von Werder K, Melmed S (2000) Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 85:526\u2013529","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR2","first-page":"3534","volume":"87","author":"PJ Trainer","year":"2002","unstructured":"Trainer PJ (2002) Editorial: Acromegaly\u2013consensus, what consensus? J Clin Endocrinol Metab 87:3534\u20133536","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR3","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1007\/BF03345228","volume":"26","author":"A Giustina","year":"2003","unstructured":"Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA, Melmed S; The Pituitary Society and the European Neuroendocrine Association (2003) Diagnosis and treatment of acromegaly complications. J Endocrinol Invest 26:1242\u20131247","journal-title":"J Endocrinol Invest"},{"key":"409_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25:102\u2013152","journal-title":"Endocr Rev"},{"key":"409_CR5","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2265.2003.01734.x","volume":"58","author":"MC Sheppard","year":"2003","unstructured":"Sheppard MC (2003) Primary medical therapy for acromegaly. Clin Endocrinol (Oxf) 58:387\u2013399","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR6","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/jc.2002-011841","volume":"87","author":"S Melmed","year":"2002","unstructured":"Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KV, Wass J, Giustina A; Acromegaly Treatment Consensus Workshop Participants (2002) Guidelines for acromegaly management. J Clin Endocrinol Metab 87:4054\u20134058","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR7","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","volume":"23","author":"JJ Kopchick","year":"2002","unstructured":"Kopchick JJ, Parkinson C, Stevens EC, Trainer PJ (2002) Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly. Endocr Rev 23:623\u2013646","journal-title":"Endocr Rev"},{"key":"409_CR8","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1210\/jcem.87.7.8665","volume":"87","author":"PU Freda","year":"2002","unstructured":"Freda PU (2002) Somatostatin analogs in acromegaly. J Clin Endocrinol Metab 87:3013\u20133018","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR9","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","volume":"358","author":"AJ Van Der Lely","year":"2001","unstructured":"Van Der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358:1754\u20131759","journal-title":"Lancet"},{"key":"409_CR10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2265.2003.01706.x","volume":"58","author":"JA Wass","year":"2003","unstructured":"Wass JA (2003) Radiotherapy in acromegaly: a protagonists viewpoint. Clin Endocrinol (Oxf) 58:128\u2013131","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR11","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2265.2003.01704.x","volume":"58","author":"AL Barkan","year":"2003","unstructured":"Barkan AL (2003) Radiotherapy in acromegaly: the argument against. Clin Endocrinol (Oxf) 58:132\u2013135","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1046\/j.1365-2265.2003.01705.x","volume":"58","author":"MO Thorner","year":"2003","unstructured":"Thorner MO (2003) Controversy: radiotherapy for acromegaly. Clin Endocrinol (Oxf) 58:136\u2013137","journal-title":"Clin Endocrinol (Oxf)"},{"key":"409_CR13","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1210\/jc.2002-020356","volume":"88","author":"FM Swords","year":"2003","unstructured":"Swords FM, Allan CA, Plowman PN, Sibtain A, Evanson J, Chew SL, Grossman AB, Besser GM, Monson JP (2003) Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas. J Clin Endocrinol Metab 88:5334\u20135340","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR14","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1210\/jcem.85.3.6464","volume":"85","author":"AM Landolt","year":"2000","unstructured":"Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, Wellis G (2000) Octreotide may act as a radioprotective agent in acromegaly. J Clin Endocrinol Metab 85:1287\u20131289","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR15","first-page":"3034","volume":"83","author":"CB Newman","year":"1998","unstructured":"Newman CB, Melmed S, George A, Torigian D, Duhaney M, Snyder P, Young W, Klibanski A, Molitch ME, Gagel R, Sheeler L, Cook D, Malarkey W, Jackson I, Vance ML, Barkan A, Frohman L, Kleinberg DL (1998) Octreotide as primary therapy for acromegaly. J Clin Endocrinol Metab 83:3034\u20133040","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR16","first-page":"2779","volume":"86","author":"A Colao","year":"2001","unstructured":"Colao A, Ferone D, Marzullo P, Cappabianca P, Cirillo S, Boerlin V, Lancranjan I, Lombardi G (2001) Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. J Clin Endocrinol Metab 86:2779\u20132786","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR17","first-page":"434","volume":"64","author":"P Jaquet","year":"2003","unstructured":"Jaquet P, Cortet-Rudelli Ch, Sassolas G, Morange-Ramos I, Chanson P, Brue T, Andrieu JM, Beckers A, Bertherat J, Borson-Chazot F, Brassier G, Caron P, Cogne M, Cottier JP, Delemer B, Dufour H, Enjalbert A, Figarella-Branger D, Gaillard R, Gueydan M, Jan M, Kuhn JM, Raingeard I, Regis J, Roger P, Rohmer V, Sadoul JL, Saveanu A, Tabarin A, Travers N, Trouillas J French Acromegly Registry (2003) Therapeutic strategies in somatotroph adenomas with extrasellar extension: role of the medical approach, a consensus study of the French Acromegaly Registry. Ann Endocrinol 64:434\u2013441","journal-title":"Ann Endocrinol"},{"key":"409_CR18","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jc.2002-020072","volume":"88","author":"A Ben-Shlomo","year":"2003","unstructured":"Ben-Shlomo A, Melmed S (2003) Clinical review 154: The role of pharmacotherapy in perioperative management of patients with acromegaly. J Clin Endocrinol Metab 88:963\u2013968","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR19","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2003-030518","volume":"88","author":"DR Clemmons","year":"2003","unstructured":"Clemmons DR, Chihara K, Freda PU, Ho KK, Klibanski A, Melmed S, Shalet SM, Strasburger CJ, Trainer PJ, Thorner MO (2003) Optimizing control of acromegaly: integrating a growth hormone receptor antagonist into the treatment algorithm. J Clin Endocrinol Metab 88:4759\u20134767","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2003-031984","volume":"89","author":"SM Shalet","year":"2004","unstructured":"Shalet SM (2004) Biochemical monitoring of disease activity after surgery for acromegaly. J Clin Endocrinol Metab 89:492\u2013494","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1530\/eje.0.1500465","volume":"150","author":"S Gullu","year":"2004","unstructured":"Gullu S, Keles H, Delibasi T, Tonyukuk V, Kamel N, Erdogan G (2004) Remission criteria for the follow-up of patients with acromegaly. Eur J Endocrinol 150:465\u2013471","journal-title":"Eur J Endocrinol"},{"key":"409_CR22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/jc.2003-030915","volume":"89","author":"O Serri","year":"2004","unstructured":"Serri O, Beauregard C, Hardy J (2004) Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly. J Clin Endocrinol Metab 89:658\u2013661","journal-title":"J Clin Endocrinol Metab"},{"key":"409_CR23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jc.2003-031316","volume":"89","author":"PU Freda","year":"2004","unstructured":"Freda PU, Nuruzzaman AT, Reyes CM, Sundeen RE, Post KD (2004) Significance of \u201cabnormal\u201d nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels. J Clin Endocrinol Metab 89:495\u2013500","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-006-0409-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11102-006-0409-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-006-0409-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T14:13:22Z","timestamp":1559571202000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11102-006-0409-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,30]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["409"],"URL":"https:\/\/doi.org\/10.1007\/s11102-006-0409-4","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,30]]}}}